Repositioning autologous stem cell transplantation in the management of newly diagnosed multiple myeloma
DOI:
https://doi.org/10.46765/2675-374X.2023v4n3p205Keywords:
Multiple myeloma, Stem cell transplantation, Immunotherapy, anti-CD38 monoclonal antibodies, Proteasome inhibitors, Immunomodulatory agentsAbstract
.
Downloads
Published
12/27/2023
How to Cite
Crusoe, E., & Costa, L. (2023). Repositioning autologous stem cell transplantation in the management of newly diagnosed multiple myeloma. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 4(3), 205. https://doi.org/10.46765/2675-374X.2023v4n3p205
Issue
Section
Original article
License
Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
